94
Views
10
CrossRef citations to date
0
Altmetric
Research Article

IMMUNOTOXICITY OF SODIUM BROMATE IN FEMALE B6C3F1 MICE: A 28-DAY DRINKING WATER STUDY

, , , , , , & show all
Pages 129-149 | Published online: 31 May 2001

REFERENCES

  • Kutom A., Bazilinski N. G., Magana L., Dunea G. Bromate Intoxication: Hairdressers’ Anuria. Am. J. Kidney Dis. 1990; 15: 84–85
  • Umemura T., Sai K., Takagi A., Hasegawa R., Kurokawa Y. A Possible Role For Cell Proliferation in Potassium Bromate (KBrO3) carcinogenesis. J. Cancer Res. Clin. Oncol. 1993; 119: 463–469
  • Creed J. T., Brockhoff C. A. Isotope Dilution Analysis of Bromate in Drinking Water Matrixes by Ion Chromatography With Inductively Coupled Plasma Mass Spectrometric Detection. Anal. Chem. 1999; 71: 722–726
  • Gosselin R. E., Hodge H. C., Smith R. P., Gleason M. N. Clinical Toxicology of Commercial Products: Acute Poisoning. 4th ed., section III, Williams & Wilkins, Baltimore 1976; 66–68
  • Wolf D. C., Crosby L. M., George M. H., Kilburn S. R., Moore T. M., Miller R. T., DeAngelo A. B. Time- and Dose-Dependent Development of Potassium Bromate-Induced Tumors in Male Fischer 344 Rats. Toxicol. Pathol. 1998; 26: 724–729
  • Carratala R., Urcaray I. Grave Intoxication Due to Ingestion of Potassium Bromate. Rev. Assoc. Med. Arg. 1941; 55: 529
  • Dunsky I. Potassium Bromate Poisoning. Am. J. Dis. Child 1947; 74: 730–734
  • Matsumoto I., Morizono T., Paparella M. M. Hearing Loss Following Potassium Bromate: Two Case Reports. Otolaryngol. Head Neck Surg. 1980; 88: 625–629
  • Gradus D., Rhoads M., Bergstrom L. B., Jordan S. C. Acute Bromate Poisoning Associated With Renal Failure and Deafness Presenting as Hemolytic Uremic Syndrome. Am. J. Nephrol. 1984; 4: 188–191
  • Kurokawa Y., Maekawa A., Takahashi M., Hayashi Y. Toxicity and Carcinogenicity of Potassium Bromate–A New Renal Carcinogen. Environ. Health Perspect. 1990; 87: 309–335
  • Guo T. L., McCay J. A., Brown R. A., Musgrove D. L., Butterworth L., Munson A. E., Germolec D. R., White K. L., Jr. Glycidol Modulation of the Immune Responses in Female B6C3F1 Mice. Drug Chem. Toxicol. 2000; 23: 433–457
  • Jerne N. K., Nordin A. A. Plaque Formation in Agar by Single Antibody-Producing Cells. Science 1963; 140: 405–406
  • Temple L., Kawabata T. T., Munson A. E., White K. L., Jr. Comparison of ELISA and Plaque-Forming Cell Assay for Measuring the Humoral Immune Response to sRBC in Animals Treated With Benzo(a)Pyrene or Cyclophosphamide. Fund. Appl. Toxicol. 1993; 21: 412–419
  • Geissler K., Tricot G., Leemhuis T., Walker E., Broxmeyer H. E. Differentiation-Inducing Effect of Recombinant Human Tumor Necrosis Factor Alpha and Gamma-Interferon In Vitro on Blast Cells From Patients With acute Myeloid Leukemia and Myeloid Blast Crisis of Chronic Myeloid Leukemia. Cancer Res. 1989; 49: 3057–3062
  • DeAngelo A. B., George M. H., Kilburn S. R., Moore T. M., Wolf D. C. Carcinogenicity of Potassium Bromate Administered in the Drinking Water to Male B6C3F1 Mice and F344/N Rats. Toxicol. Pathol. 1998; 26: 587–594
  • McLaren J., Boulikas T., Vamvakas S. Induction of Poly(ADP-ribosyl)ation in the Kidney After In Vivo Application of Renal Carcinogens. Toxicology 1994; 88: 101–112
  • Baccarini M., Bistoni F., Lohmann-Matthes M. L. Organ-Associated Macrophage Precursor Activity: Isolation of Candidacidal and Tumoricidal Effectors From the Spleens of Cyclophosphamide-Treated Mice. J. Immunol. 1986; 136: 837–843

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.